Withdrawal of immunosuppression in liver transplantation and the mechanism of tolerance

Wimmer, 2013, Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients, Transpl Int, 26, 999, 10.1111/tri.12165 Teperman, 2013, Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial, Liver Transpl, 19, 675, 10.1002/lt.23658 Zivković, 2010, Neurologic manifestations of transplant complications, Neurol Clin, 28, 235, 10.1016/j.ncl.2009.09.011 Mucha, 2013, Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient, Ann Transplant, 18, 238, 10.12659/AOT.883921 Benítez, 2013, Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients, Hepatology, 58, 1824, 10.1002/hep.26426 Barbier, 2013, Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors, J Hepatol, 59, 1223, 10.1016/j.jhep.2013.07.032 de la Garza, 2013, Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance, Liver Transpl, 19, 937, 10.1002/lt.23686 Mazariegos, 2007, Clinical tolerance following liver transplantation: long term results and future prospects, Transpl Immunol, 17, 114, 10.1016/j.trim.2006.09.033 Feng, 2012, Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants, JAMA, 307, 283, 10.1001/jama.2011.2014 Liu, 2013, Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects, Hepatobiliary Pancreat Dis Int, 12, 12, 10.1016/S1499-3872(13)60002-8 Lerut, 2006, An appraisal of tolerance in liver transplantation, Am J Transplant, 6, 1774, 10.1111/j.1600-6143.2006.01396.x Martínez-Llordella, 2008, Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients, J Clin Invest, 118, 2845 Tisone, 2006, Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence, J Hepatol, 44, 702, 10.1016/j.jhep.2005.11.047 Assy, 2007, Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid, Transplantation, 83, 1571, 10.1097/01.tp.0000266678.32250.76 Pons, 2008, FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal, Transplantation, 86, 1370, 10.1097/TP.0b013e318188d3e6 Samonakis, 2006, Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis, Transpl Infect Dis, 8, 3, 10.1111/j.1399-3062.2006.00124.x Lerut, 2008, Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study, Ann Surg, 248, 956, 10.1097/SLA.0b013e31819009c9 Bourdeaux, 2013, Prope tolerance after pediatric liver transplantation, Pediatr Transplant, 17, 59, 10.1111/petr.12024 Ueda, 2006, Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center, Liver Transpl, 12, 1326, 10.1002/lt.20826 Koshiba, 2007, Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation, Transpl Immunol, 17, 94, 10.1016/j.trim.2006.10.004 Egawa, 2012, Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal, Hepatol Res, 42, 895, 10.1111/j.1872-034X.2012.01003.x McCaughan, 2013, Operational tolerance in liver transplantation: shall we predict or promote?, Liver Transpl, 19, 933, 10.1002/lt.23719 Bilate, 2012, Induced CD4+Foxp3+ regulatory T cells in immune tolerance, Annu Rev Immunol, 30, 733, 10.1146/annurev-immunol-020711-075043 Xie, 2013, Immune tolerance induced by RelB short-hairpin RNA interference dendritic cells in liver transplantation, J Surg Res, 180, 169, 10.1016/j.jss.2012.10.021 Verdonk, 2011, A prospective analysis of the natural course of donor chimerism including the natural killer cell fraction after liver transplantation, Transplantation, 92, e22, 10.1097/TP.0b013e318225283e Chen, 2008, Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats, Liver Transpl, 14, 823, 10.1002/lt.21450 Starzl, 2003, Tolerogenic immunosuppression for organ transplantation, Lancet, 361, 1502, 10.1016/S0140-6736(03)13175-3 Eason, 2005, Tolerance: is it worth the risk?, Transplantation, 79, 1157, 10.1097/01.TP.0000162084.46555.10 Assy, 2007, A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients, Gut, 56, 304, 10.1136/gut.2006.107862 Donckier, 2006, Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion, Liver Transpl, 12, 1523, 10.1002/lt.20872 Matthes-Martin, 2000, Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis, Blood, 96, 3997, 10.1182/blood.V96.12.3997 Tryphonopoulos, 2005, The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation, Am J Transplant, 5, 608, 10.1111/j.1600-6143.2004.00743.x Mathew, 2003, Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation, Transpl Immunol, 11, 307, 10.1016/S0966-3274(03)00056-X Hematti, 2008, Role of mesenchymal stromal cells in solid organ transplantation, Transplant Rev (Orlando), 22, 262, 10.1016/j.trre.2008.05.002 Bishop, 2011, Approaching the promise of operational tolerance in clinical transplantation, Transplantation, 91, 1065, 10.1097/TP.0b013e318215e742 Li, 2012, A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation, Am J Transplant, 12, 1218, 10.1111/j.1600-6143.2011.03928.x Mazariegos, 2005, Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression, Am J Transplant, 5, 314, 10.1111/j.1600-6143.2004.00672.x Castellaneta, 2011, HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance, Transplantation, 91, 1132, 10.1097/TP.0b013e31821414c9 Orlando, 2009, Operational tolerance after liver transplantation, J Hepatol, 50, 1247, 10.1016/j.jhep.2009.03.006 Jones, 2009, Memory T cells: how might they disrupt the induction of tolerance?, Transplantation, 87, S74, 10.1097/TP.0b013e3181a2b83b Donckier, 2013, Expansion of memory-type CD8+ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycin, Transplantation, 96, 306, 10.1097/TP.0b013e3182985414 Sun, 2009, Immunophenotypic shift of memory CD8 T cells identifies the changes of immune status in the patients after liver transplantation, Scand J Clin Lab Invest, 69, 789, 10.3109/00365510903268818 Jones, 2006, Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants, Transplantation, 82, 1352, 10.1097/01.tp.0000241077.83511.be Mineharu, 2014, Blockade of mTOR signaling via rapamycin combined with immunotherapy augments antiglioma cytotoxic and memory T-cell functions, Mol Cancer Ther, 13, 3024, 10.1158/1535-7163.MCT-14-0400 Liu, 2013, CD4(+) T-cell subsets in transplantation, Immunol Rev, 252, 183, 10.1111/imr.12038 Sakaguchi, 2005, Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self, Nat Immunol, 6, 345, 10.1038/ni1178 Shalev, 2011, Making sense of regulatory T cell suppressive function, Semin Immunol, 23, 282, 10.1016/j.smim.2011.04.003 Yu, 2013, CD4+CD25+ regulatory T cells-derived exosomes prolonged kidney allograft survival in a rat model, Cell Immunol, 285, 62, 10.1016/j.cellimm.2013.06.010 Fan, 2011, Regulatory T cell therapy for the induction of clinical organ transplantation tolerance, Semin Immunol, 23, 453, 10.1016/j.smim.2011.08.012 Wood, 2012, Regulatory immune cells in transplantation, Nat Rev Immunol, 12, 417, 10.1038/nri3227 Graca, 2002, Identification of regulatory T cells in tolerated allografts, J Exp Med, 195, 1641, 10.1084/jem.20012097 Li, 2008, New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells, Am J Transplant, 8, 1639, 10.1111/j.1600-6143.2008.02300.x Xie, 2012, Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance, Liver Transpl, 18, 444, 10.1002/lt.22480 Salomon, 2000, B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes, Immunity, 12, 431, 10.1016/S1074-7613(00)80195-8 Morgan, 2005, Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans, Hum Immunol, 66, 13, 10.1016/j.humimm.2004.05.016 Krüger, 2008, Genetic polymorphisms and the fate of the transplanted organ, Transplant Rev (Orlando), 22, 131, 10.1016/j.trre.2007.12.002 Critchley, 2012, Graft rejection – endogenous or allogeneic?, Immunology, 136, 123, 10.1111/j.1365-2567.2012.03560.x Zhang, 2013, The immunosuppressant protosappanin A promotes dendritic cellmediated expansion of alloantigen-specific tregs and prolongs allograft survival in rats, PLoS One, 8, e66336, 10.1371/journal.pone.0066336 Guo, 2012, Central and overlapping role of Cathepsin B and inflammasome adaptor ASC in antigen presenting function of human dendritic cells, Hum Immunol, 73, 871, 10.1016/j.humimm.2012.06.008 Kupz, 2012, NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8+ T cells, Nat Immunol, 13, 162, 10.1038/ni.2195 Beynon, 2012, Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling, PLoS One, 7, e39576, 10.1371/journal.pone.0039576